Retatrutide is a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By activating these receptors, https://prestonqcqa008871.activoblog.com/41238112/retatrutide-a-promising-new-treatment-for-obesity